Dystrophin binds with equal avidity to muscle and brain F-actin, suggesting preferential binding to nonmuscle actin is not the basis for its targeting to the muscle cell plasmalemma.
No takes yet. Share an insight, caveat, or question.
Rules out preferential nonmuscle actin binding for dystrophin targeting; leaves open plasmalemma localization mechanisms in dystrophy models.
Renley et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: